UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EP217/#745 COVID-19 effects on ovarian cancer diagnosis, treatment patterns, and survival

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A166-A167

2023

Volltextzugriff (PDF)

The effect of food deserts on gynecologic cancer survival

Gynecologic oncology reports, 2024-08, Vol.54, p.101430, Article 101430

2024

Volltextzugriff (PDF)

Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer

Journal for immunotherapy of cancer, 2024-04, Vol.12 (4), p.e007716

2024

Volltextzugriff (PDF)

Differences in Family Planning and Fertility Among Female and Male Gynecologic Oncologists

Women's health reports (New Rochelle, N.Y.), 2021-04, Vol.2 (1), p.78-84

2021

Volltextzugriff (PDF)

Pilomatrix carcinoma of the vulva

Gynecologic oncology reports, 2016-01, Vol.15 (C), p.9-11

2016

Volltextzugriff (PDF)

Racial and ethnic inequities in end-of-life care intensity among patients with gynecologic cancers in California

Gynecologic oncology, 2024-11, Vol.190, p.S72-S73

2024

Volltextzugriff (PDF)

Minimally invasive surgery for endometrial cancer: A decade-long, 265,000 patient experience from the national cancer database (1234)

Gynecologic oncology, 2023-09, Vol.176, p.S150-S150

2023

Volltextzugriff (PDF)

Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Clinical cancer research, 2022-01, Vol.28 (1), p.201-214

2022

Volltextzugriff (PDF)

Aggressive Angiomyxoma of the Vulva and Bladder

Obstetrics and gynecology (New York. 1953), 2017-10, Vol.130 (4), p.885-888

2017

Volltextzugriff (PDF)

Gynecological cancer survival and association with food deserts (037)

Gynecologic oncology, 2023-09, Vol.176, p.S27-S27

2023

Volltextzugriff (PDF)

Re-staging endometrial cancer patients according to the 2023 FIGO guidelines demonstrates no difference in survival by stage: A large, retrospective cohort validated by the TCGA dataset

Gynecologic oncology, 2024-11, Vol.190, p.S195-S196

2024

Volltextzugriff (PDF)

Low-grade endometrial cancer histology at diagnosis does not improve survival in the TP53 molecular subtype regardless of stage: A large, retrospective cohort validated by the Cancer Genome Atlas dataset

Gynecologic oncology, 2024-11, Vol.190, p.S99-S99

2024

Volltextzugriff (PDF)

Bilateral oophorectomy and colorectal cancer incidence and mortality in the Women's Health Initiative

Cancer epidemiology, biomarkers & prevention, 2023-11, Vol.32 (11), p.1668-1671

2023

Volltextzugriff (PDF)

STAT3 is a potential therapeutic target in cervical cancer (257)

Gynecologic oncology, 2022-08, Vol.166, p.S137-S138

2022

Volltextzugriff (PDF)

The effects of the Covid-19 pandemic on practice patterns and outcomes in patients diagnosed with gynecologic malignancies in the United States

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5523-5523

2023

Volltextzugriff (PDF)

The effect of megestrol acetate ± pterostilbene in endometrial cancer: A prospective, randomized, window-of-opportunity clinical trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5597-5597

2023

Volltextzugriff (PDF)

PR043/#416 Restaging uterine cancer patients with the 2023 FIGO guidelines: clinical characteristics and survival differences

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A53-A55

2023

Volltextzugriff (PDF)

EP017/#738 Insights from ovarian cancer patients’ rapid autopsy shed light on mechanisms of CD4+ T cell-mediated pre-metastatic niche formation through the STAT3 axis

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A91-A92

2023

Volltextzugriff (PDF)

Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials

Journal of clinical oncology, 2024-10, Vol.42 (30), p.3537-3549

2024

Volltextzugriff (PDF)

MSOR9 Presentation Time: 5:25 PM

Brachytherapy, 2023-09, Vol.22 (5), p.S43

2023

Volltextzugriff (PDF)

MSOR9 Presentation Time: 5:25 PM: Explainable Artificial Intelligence to Characterize Receipt of Brachytherapy Boost in Locally Advanced Cervical Cancer Through the COVID-19 Era

Brachytherapy, 2023-09, Vol.22 (5), p.S43-S43

2023

Volltextzugriff (PDF)

A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

Molecular therapy, 2024-10, Vol.32 (10), p.3629-3649

2024

Volltextzugriff (PDF)

L1 cell adhesion molecule (L1CAM) expression in endometrial cancer is associated with SRC pathway activation with potential for targeted therapy with dasatinib

Gynecologic oncology, 2021-08, Vol.162, p.S195-S195

2021

Volltextzugriff (PDF)

Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era

Brachytherapy, 2024-05, Vol.23 (3), p.237-247

2024

Volltextzugriff (PDF)

Incorporation of HIPEC into a high volume ovarian cancer program: Initial results and outcomes

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17040-e17040

2019

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(40)
Berichte
(1)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(11)
Oncology
(10)
Female
(8)
Obstetrics & Gynecology
(8)
Middle Aged
(6)
Aged
(5)
Ovarian Cancer
(5)
Animals
(4)
Adult
(3)
Cancer Therapies
(3)
Chemotherapy
(3)
Mice
(3)
Tumors
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Autopsies
(2)
Biopsy
(2)
Case Report
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

EP217/#745 COVID-19 effects on ovarian cancer diagnosis, treatment patterns, and survival

The effect of food deserts on gynecologic cancer survival

Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer

Differences in Family Planning and Fertility Among Female and Male Gynecologic Oncologists

Pilomatrix carcinoma of the vulva

Racial and ethnic inequities in end-of-life care intensity among patients with gynecologic cancers in California

Minimally invasive surgery for endometrial cancer: A decade-long, 265,000 patient experience from the national cancer database (1234)

Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Aggressive Angiomyxoma of the Vulva and Bladder

Gynecological cancer survival and association with food deserts (037)

Re-staging endometrial cancer patients according to the 2023 FIGO guidelines demonstrates no difference in survival by stage: A large, retrospective cohort validated by the TCGA dataset

Low-grade endometrial cancer histology at diagnosis does not improve survival in the TP53 molecular subtype regardless of stage: A large, retrospective cohort validated by the Cancer Genome Atlas dataset

Bilateral oophorectomy and colorectal cancer incidence and mortality in the Women's Health Initiative

STAT3 is a potential therapeutic target in cervical cancer (257)

The effects of the Covid-19 pandemic on practice patterns and outcomes in patients diagnosed with gynecologic malignancies in the United States

The effect of megestrol acetate ± pterostilbene in endometrial cancer: A prospective, randomized, window-of-opportunity clinical trial

PR043/#416 Restaging uterine cancer patients with the 2023 FIGO guidelines: clinical characteristics and survival differences

EP017/#738 Insights from ovarian cancer patients’ rapid autopsy shed light on mechanisms of CD4+ T cell-mediated pre-metastatic niche formation through the STAT3 axis

Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials

MSOR9 Presentation Time: 5:25 PM

MSOR9 Presentation Time: 5:25 PM: Explainable Artificial Intelligence to Characterize Receipt of Brachytherapy Boost in Locally Advanced Cervical Cancer Through the COVID-19 Era

A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

L1 cell adhesion molecule (L1CAM) expression in endometrial cancer is associated with SRC pathway activation with potential for targeted therapy with dasatinib

Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era

Incorporation of HIPEC into a high volume ovarian cancer program: Initial results and outcomes

Suchergebnisse filtern